Vandervoort Adam C's Form 4 filing
Teladoc Health, Inc. (TDOC) · filed Mar 3, 2023
- Accession no.
- 0001415889-23-004103
- Filed
- Mar 3, 2023
- Trade date
- Mar 1-2, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 8 derivative transactions. Open-market sales total $98.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vandervoort Adam CCIK 0001375088 | Officer (CHIEF LEGAL OFFICER, SECRETARY) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | Common Stock | MOption exerciseAcquired | +7,523 | –F1 | – | 19,506 | Direct | |
| Mar 2, 2023 | Common Stock | SSaleDisposed | −3,877 | $25.36 | −$98,320.72 | 15,629 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseAcquired | +1,941 | –F1 | – | 17,570 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseAcquired | +3,300 | –F3 | – | 20,870 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseAcquired | +831 | –F3 | – | 21,701 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseAcquired | +1,912 | –F1 | – | 23,613 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseAcquired | +1,445 | –F3 | – | 25,058 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseAcquired | +727 | –F3 | – | 25,785 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | Common Stock | MOption exerciseDisposed | −7,523 | $0.00 | $0 | 15,048 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseDisposed | −1,941 | $0.00 | $0 | 0 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseDisposed | −3,300 | $0.00 | $0 | 0 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseDisposed | −831 | $0.00 | $0 | 0 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseDisposed | −1,912 | $0.00 | $0 | 1,912 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseDisposed | −1,445 | $0.00 | $0 | 1,446 | Direct | |
| Mar 2, 2023 | Common Stock | AGrant or awardAcquired | +1,457 | $0.00 | $0 | 1,457 | Direct | |
| Mar 2, 2023 | Common Stock | MOption exerciseDisposed | −727 | $0.00 | $0 | 730 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Referenced by the price of 3 transactions in Table I.
- F3
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Referenced by the price of 4 transactions in Table I.